The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

被引:38
|
作者
Chan, Dennis [1 ]
Gallaher, Laura Marie [2 ]
Moodley, Kuven [2 ]
Minati, Ludovico [3 ]
Burgess, Neil [4 ]
Hartley, Tom [5 ]
机构
[1] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 1TN, England
[2] Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Brighton, E Sussex, England
[3] Fdn IRCCS Ist Neurol Carlo Besta, UO Direzione Sci, Milan, Italy
[4] UCL, Inst Cognit Neurosci, London WC1E 6BT, England
[5] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England
来源
基金
英国惠康基金; 英国医学研究理事会;
关键词
Behavior; Issue; 116; Alzheimer's disease; mild cognitive impairment; spatial memory; hippocampus; 4 Mountains Test; pre-dementia Alzheimer's disease; MILD COGNITIVE IMPAIRMENT; TOPOGRAPHICAL MEMORY; HIPPOCAMPUS; ASSOCIATION; NETWORKS; STATE;
D O I
10.3791/54454
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This protocol describes the administration of the 4 Mountains Test (4MT), a short test of spatial memory, in which memory for the topographical layout of four mountains within a computer-generated landscape is tested using a delayed match-to-sample paradigm. Allocentric spatial memory is assessed by altering the viewpoint, colors and textures between the initially presented and target images. Allocentric spatial memory is a key function of the hippocampus, one of the earliest brain regions to be affected in Alzheimer's disease (AD) and impairment of hippocampal function predates the onset of dementia. It was hypothesized that performance on the 4MT would aid the diagnosis of predementia AD, which manifests clinically as Mild Cognitive Impairment (MCI). The 4MT was applied to patients with MCI, stratified further based on cerebrospinal fluid (CSF) AD biomarker status (10 MCI biomarker positive, 9 MCI biomarker negative), and with mild AD dementia, as well as healthy controls. Comparator tests included tests of episodic memory and attention widely accepted as sensitive measures of early AD. Behavioral data were correlated with quantitative MRI measures of the hippocampus, precuneus and posterior cingulate gyrus. 4MT scores were significantly different between the two MCI groups (p = 0.001), with a test score of = 8/15 associated with 100% sensitivity and 78% specificity for the classification of MCI with positive AD biomarkers, i. e., predementia AD. 4MT test scores correlated with hippocampal volume (r = 0.42) and cortical thickness of the precuneus (r = 0.55). In conclusion, the 4MT is effective in identifying the early stages of AD. The short duration, easy application and scoring, and favorable psychometric properties of the 4MT fulfil the need for a simple but accurate diagnostic test for predementia AD.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] The placing test: Preliminary investigations of a quick and simple memory test designed to be sensitive to pre-dementia Alzheimer's disease but not to normal ageing
    Anderson, Elizabeth J.
    de Jager, Celeste A.
    Iversen, Susan D.
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2006, 28 (06) : 843 - 858
  • [2] Subjective Memory Impairment at the Pre-Dementia Stage of Alzheimer's Disease
    Jessen, F.
    JOURNAL OF PSYCHOPHYSIOLOGY, 2013, 27 : 28 - 29
  • [3] Pre-Dementia Diagnosis of Alzheimer's Disease: Translating Clinicobiologic Research into Practice
    Dickerson, Bradford C.
    CURRENT PSYCHIATRY REVIEWS, 2008, 4 (02) : 73 - 79
  • [4] Clinical Approach to Diagnosis of Pre-Dementia Alzheimer's Disease (CAD-PAD)
    Alom, J.
    Llinares, I.
    Fajardo, S.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2012, 2 (01) : 332 - 342
  • [5] Genome research in pre-dementia stages of Alzheimer's disease
    Moreno-Grau, Sonia
    Ruiz, Agustin
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2016, 18
  • [6] Defining and describing the pre-dementia stages of familial Alzheimer's disease
    Natalie S Ryan
    Martin N Rossor
    Alzheimer's Research & Therapy, 3
  • [7] Defining and describing the pre-dementia stages of familial Alzheimer's disease
    Ryan, Natalie S.
    Rossor, Martin N.
    ALZHEIMERS RESEARCH & THERAPY, 2011, 3 (05):
  • [8] Subjective cognitive decline at the pre-dementia stage in Alzheimer's disease
    Jessen, F.
    NERVENHEILKUNDE, 2013, 32 (10) : 715 - 719
  • [9] Independent contribution of temporal β-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease
    Chetelat, Gael
    Villemagne, Victor L.
    Pike, Kerryn E.
    Ellis, Kathryn A.
    Bourgeat, Pierrick
    Jones, Gareth
    O'Keefe, Graeme J.
    Salvado, Olivier
    Szoeke, Cassandra
    Martins, Ralph N.
    Ames, David
    Masters, Colin L.
    Rowe, Christopher C.
    BRAIN, 2011, 134 : 798 - 807
  • [10] Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer’s disease
    Frank Jessen
    European Archives of Psychiatry and Clinical Neuroscience, 2014, 264 : 3 - 7